GZ is not looped into the back and forth with MHRA. And even if he is, it not been public info, his hands are tied. He can’t be specific about anything. He is responsive though. Both he and Dave Innes have answered my calls. Even Les use to. I’ve even asked them if an RS can be done (though it hurts us retail investors) to uplist. They’ve always maintained, they don’t know and it’s not up to them. I don’t think anything can really be done strategically by the management till approval. Uplisting now would tie their hands in terms of dilutions. And without diluting, keeping the lights on would be even more difficult. So we are, for a lack of a better word, trapped, till this tunnel opens up into some kind of a light, however faint. I really do dread the ensuing months without approval.
Market Data 
Markets 
AI
